Work

Nanoparticles with SGLT2 inhibitory activity: Possible benefits and future

Year: 2023

Type: review

Source: Diabetes & Metabolic Syndrome Clinical Research & Reviews

DOI: 10.1016/j.dsx.2023.102869

Authors: Habib Yaribeygi, Mina Maleki, Tannaz Jamialahmadi, Nikolay K. Shakhpazyan, Prashant Kesharwani, Amirhossein Sahebkar

Institutions: Semnan University of Medical Sciences, Shahid Beheshti University, Shahid Beheshti University of Medical Sciences, Mashhad University of Medical Sciences, Russian Scientific Center of Surgery, Jamia Hamdard, Saveetha University

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Russian Science Foundation

Award: G1922354821

OpenAlex ID: W4387007520

FWCI: 0.148

Cites: 63

Cited by: 5

Related to: 10